Parkside Financial Bank & Trust - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$6,756
+33.0%
721
+248.3%
0.00%
+100.0%
Q2 2023$5,078
-54.8%
207
-57.1%
0.00%
-66.7%
Q1 2023$11,240
-6.5%
483
+1.7%
0.00%0.0%
Q4 2022$12,023
+100.4%
475
+42.6%
0.00%
+50.0%
Q3 2022$6,000
-14.3%
333
+23.3%
0.00%0.0%
Q2 2022$7,0002700.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders